Lv5
808 积分 2021-12-18 加入
Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): an open-label, superiority and non-inferiority, phase 3 randomised controlled trial
6小时前
待确认
Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): final report of a randomised, open-label, phase 3 trial
6小时前
待确认
Histopathologic Predictors of Survival and Recurrence in Resected Ampullary Adenocarcinoma
8个月前
已完结
How to find a needle in a haystack: a systematic review on targeting KRAS wild-type pancreatic cancer
11个月前
已完结
Predicting Microvascular Invasion in Hepatocellular Carcinoma Using CT-based Radiomics Model
1年前
已完结
MRI‐Based Radiomics and Deep Learning in Biological Characteristics and Prognosis of Hepatocellular Carcinoma: Opportunities and Challenges
1年前
已完结
Biomarkers for immunotherapy of hepatocellular carcinoma
1年前
已完结
Short-term Outcomes of Robotic Versus Open Pancreatoduodenectomy - Propensity Score-matched Analysis
1年前
已完结
Radiomics-guided prognostic assessment of early-stage hepatocellular carcinoma recurrence post-radical resection
1年前
已完结
Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial
1年前
已完结
皖公网安备34019202002308
